Pilot study of reloxaliase in patients with severe enteric hyperoxaluria and hyperoxalemia
Subsequent urinary stone events are predicted by the magnitude of urinary oxalate excretion in enteric hyperoxaluria
Safety and Efficacy of Reloxaliase in Enteric Hyperoxaluria (EH): An Aggregate Review of Completed Studies.
Establishing Safety and Efficacy of Reloxaliase in Patients with Enteric Hyperoxaluria (URIROX-2).
Pharmacodynamic (PD) Profiling of Reloxaliase in Patients with Severe Hyperoxaluria.
Establishing the Safety and Efficacy of Reloxaliase in Patients With Enteric Hyperoxaluria (URIROX-2): A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study.
A Phase 3, Randomized, Placebo-Controlled Trial of Reloxaliase in Enteric Hyperoxaluria (URIROX-1): Clinical Characteristics and Burden of Illness.
Pilot Study of Reloxaliase in Patients with Severe Enteric Hyperoxaluria and Hyperoxalemia: A Pro Tem Analysis of Study ALLN-177-206.
Dietary Oxalate Ingestion, Urinary Oxalate Levels, and Response to Reloxaliase in Three Phase II Studies.